High-entropy alloys (HEAs) with high melting points and low thermal neutron cross-section are promising new cladding materials for generation III+ and IV power reactors. In this study a recently developed high throughput computational screening tool Alloy Search and Predict (ASAP) has been used to identify the most likely candidate single-phase HEAs with low thermal neutron cross-section, from over a million four-element equimolar combinations. The selected NbTiVZr HEA was further studied by density functional theory (DFT) for moduli and lattice parameter, and by CALPHAD to predict phase formation with temperature. HEAs of NbTiVZrx (x = 0.5, 1, 2) were produced experimentally, with Zr varied as the dominant cross-section modifier. Contrary to previous experimental work, these HEAs were demonstrated to constitute a single-phase HEA system; a result obtained using a faster cooling rate following annealing at 1200°C. However, the beta (BCC) matrix decomposed following aging at 700°C, into a combination of nano-scale beta, alpha (HCP) and C15 Laves phases.
The corrosion behavior of the FCC Cr18Mn27Fe27.5Ni27.5 high entropy alloy (HEA) after exposure to molten FLiBe salt at 700 °C for 1000 hours, has been investigated. Results show that the HEA lost a higher mass compared to the reference 316 H stainless steel due to the dissolution of Mn into the molten salt. The loss of Mn from the alloy appeared to discourage the dissolution of Cr in the molten fluoride salts which is widely recognized as the mechanism of corrosion degradation. Thermal exposure at 700 °C for 1000 hours also led to the precipitation of an additional BCC phase Cr67Fe13Mn18.5Ni1.5, which was confirmed by CALPHAD predictions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.